According to our previous work [17], HSA-functionalized IONPs could be present at least for 14 days in inoculated hepatocellular carcinoma PC-1 without immediate or delayed adverse reactions, and no remarkable systemic toxic effects were reported over 14 days of follow-up. The gene discussed is ALB; the disease is hepatocellular carcinoma.